Mannheim, Germany

Alisa Strobel

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Merck Life Science Kgaa. Active years: 2025.


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alisa Strobel: Innovator in Glycoform Purification

Introduction

Alisa Strobel is a prominent inventor based in Mannheim, Germany. She has made significant contributions to the field of glycoform purification, showcasing her expertise and innovative spirit. With a focus on developing methods for the separation and purification of glycoforms, her work has implications for various applications in biotechnology and pharmaceuticals.

Latest Patents

Alisa Strobel holds a patent for her invention titled "Glycoform purification." This patent describes a method for the separation and purification of glycoforms using an ion exchange separation material with amino-acid based endgroups. Her innovative approach addresses challenges in the purification process, enhancing efficiency and effectiveness.

Career Highlights

Alisa is currently employed at Merck Patent GmbH, where she continues to advance her research and development efforts. Her work at Merck has allowed her to collaborate with leading experts in the field, further enriching her contributions to innovation.

Collaborations

Alisa Strobel has worked alongside talented colleagues, including Romas Skudas and Annika Holzgreve. These collaborations have fostered a dynamic environment for innovation and have led to the development of cutting-edge solutions in glycoform purification.

Conclusion

Alisa Strobel's contributions to the field of glycoform purification exemplify her dedication to innovation and research. Her patent and work at Merck Patent GmbH highlight her role as a key player in advancing biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…